Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5182436
Max Phase: Preclinical
Molecular Formula: C26H41NO32S4
Molecular Weight: 1007.86
Associated Items:
ID: ALA5182436
Max Phase: Preclinical
Molecular Formula: C26H41NO32S4
Molecular Weight: 1007.86
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3[C@H](CSO)[C@@H](OS(=O)(=O)O)[C@@H](O[C@H]4[C@H](O)[C@@H](OS(=O)(=O)O)[C@H](O)O[C@H]4C(=O)O)O[C@@H]3O)O[C@@H]2C(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C26H41NO32S4/c1-4(28)27-7-9(30)8(29)6(2-50-61(41,42)43)51-24(7)54-15-10(31)11(32)25(56-19(15)21(36)37)53-13-5(3-60-40)14(58-62(44,45)46)26(57-22(13)38)55-16-12(33)17(59-63(47,48)49)23(39)52-18(16)20(34)35/h5-19,22-26,29-33,38-40H,2-3H2,1H3,(H,27,28)(H,34,35)(H,36,37)(H,41,42,43)(H,44,45,46)(H,47,48,49)/t5-,6+,7+,8+,9+,10+,11+,12-,13-,14+,15-,16-,17+,18+,19-,22-,23+,24+,25+,26-/m0/s1
Standard InChI Key: CEUWOBRJYFGRQF-VPLKLZIGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1007.86 | Molecular Weight (Monoisotopic): 1007.0495 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. González-Cardenete MA, Hamulić D, Miquel-Leal FJ, González-Zapata N, Jimenez-Jarava OJ, Brand YM, Restrepo-Mendez LC, Martinez-Gutierrez M, Betancur-Galvis LA, Marín ML.. (2022) Antiviral Profiling of C-18- or C-19-Functionalized Semisynthetic Abietane Diterpenoids., 85 (8.0): [PMID:35969814] [10.1021/acs.jnatprod.2c00464] |
Source(1):